☰

Jeremy B. Foote, Ph.D. - Publications

Affiliations: 
2009 Microbiology University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
Microbiology Biology, Immunology
Tree Info Similar researchers PubMed Report error

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Lopez-Bujanda ZA, Chaimowitz MG, Armstrong TD, Foote JB, Emens LA, Drake CG. Robust antigen-specific CD8 T cell tolerance to a model prostate cancer neoantigen. Oncoimmunology. 9: 1809926. PMID 33457094 DOI: 10.1080/2162402X.2020.1809926  0.333
2020 Cooper DKC, Hara H, Iwase H, Yamamoto T, Wang ZY, Jagdale A, Bikhet MH, Nguyen HQ, Foote JB, Paris WD, Ayares D, Kumar V, Anderson DJ, Locke JE, Eckhoff DE. Pig Kidney Xenotransplantation: Progress Towards Clinical Trials. Clinical Transplantation. e14139. PMID 33131148 DOI: 10.1016/J.Healun.2020.08.009  0.305
2020 Chambers MR, Bentley RT, Crossman DK, Foote JB, Koehler JW, Markert JM, Omar NB, Platt SR, Self DM, Shores A, Sorjonen DC, Waters AM, Yanke AB, Gillespie GY. The One Health Consortium: Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Combination With a Checkpoint Inhibitor in Canine Patients With Sporadic High Grade Gliomas. Frontiers in Surgery. 7: 59. PMID 33005623 DOI: 10.3389/Fsurg.2020.00059  0.328
2020 Yamamoto T, Hara H, Iwase H, Jagdale A, Bikhet MH, Morsi MA, Cui Y, Nguyen HQ, Wang ZY, Anderson DJ, Foote J, Schuurman HJ, Ayares D, Eckhoff DE, Cooper DKC. The final obstacle to successful pre-clinical xenotransplantation? Xenotransplantation. e12596. PMID 32585053 DOI: 10.1111/Xen.12596  0.336
2020 Foote JB, Sarvesh S, Emens LA. Cytokine profiling of tumor-infiltrating T lymphocytes by flow cytometry. Methods in Enzymology. 631: 1-20. PMID 31948543 DOI: 10.1016/Bs.Mie.2019.08.015  0.366
2017 Foote JB, Kok M, Leatherman JM, Armstrong TD, Marcinkowski BC, Ojalvo LS, Kanne DB, Jaffee EM, Dubensky TW, Emens LA. A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice. Cancer Immunology Research. PMID 28483787 DOI: 10.1158/2326-6066.Cir-16-0284  0.382
2017 Sunay MM, Foote JB, Leatherman JM, Edwards JP, Armstrong TD, Nirschl CJ, Hicks J, Emens LA. Sorafenib combined with HER-2 targeted vaccination can promote effective T cell immunity in vivo. International Immunopharmacology. 46: 112-123. PMID 28282575 DOI: 10.1016/J.Intimp.2017.02.028  0.359
2017 Foote JB, Kok M, Leatherman JM, Armstrong TD, Marcinkowski B, Kanne DB, Jaffee EM, Dubensky TW, Emens LA. Abstract 2993: STING signaling in breast tumor microenvironment modulates immune checkpoint blockade efficacy in the neu-N mouse model of breast cancer Cancer Research. 77: 2993-2993. DOI: 10.1158/1538-7445.Am2017-2993  0.394
2015 Foote J, Leatherman JM, Amstrong TD, Ojalvo L, Kanne D, Jaffee EM, Dubensky T, Emens L. Direct activation of STING in the tumor microenvironment partially overcomes immune tolerance in neu-N transgenic mice Journal For Immunotherapy of Cancer. 3. DOI: 10.1186/2051-1426-3-S2-P356  0.35
2014 Foote JB, Kabir FM, Graff EC, Cattley RC, DeInnocentes P, Smith BF, Bird RC. Engraftment of canine peripheral blood lymphocytes into nonobese diabetic-severe combined immune deficient IL-2R common gamma chain null mice. Veterinary Immunology and Immunopathology. 157: 131-41. PMID 24368085 DOI: 10.1016/J.Vetimm.2013.11.007  0.38
2012 Vale AM, Foote JB, Granato A, Zhuang Y, Pereira RM, Lopes UG, Bellio M, Burrows PD, Schroeder HW, Nobrega A. A rapid and quantitative method for the evaluation of V gene usage, specificities and the clonal size of B cell repertoires. Journal of Immunological Methods. 376: 143-9. PMID 22226792 DOI: 10.1016/J.Jim.2011.12.005  0.388
2012 Foote JB, Mahmoud TI, Vale AM, Kearney JF. Long-term maintenance of polysaccharide-specific antibodies by IgM-secreting cells. Journal of Immunology (Baltimore, Md. : 1950). 188: 57-67. PMID 22116821 DOI: 10.4049/Jimmunol.1100783  0.536
2011 You Y, Myers RC, Freeberg L, Foote J, Kearney JF, Justement LB, Carter RH. Marginal zone B cells regulate antigen capture by marginal zone macrophages. Journal of Immunology (Baltimore, Md. : 1950). 186: 2172-81. PMID 21257969 DOI: 10.4049/Jimmunol.1002106  0.555
2009 Foote JB, Kearney JF. Generation of B cell memory to the bacterial polysaccharide alpha-1,3 dextran. Journal of Immunology (Baltimore, Md. : 1950). 183: 6359-68. PMID 19841173 DOI: 10.4049/Jimmunol.0902473  0.592
2006 Won WJ, Foote JB, Odom MR, Pan J, Kearney JF, Davis RS. Fc receptor homolog 3 is a novel immunoregulatory marker of marginal zone and B1 B cells. Journal of Immunology (Baltimore, Md. : 1950). 177: 6815-23. PMID 17082595 DOI: 10.4049/Jimmunol.177.10.6815  0.613
2005 Lopes-Carvalho T, Foote J, Kearney JF. Marginal zone B cells in lymphocyte activation and regulation. Current Opinion in Immunology. 17: 244-50. PMID 15886113 DOI: 10.1016/J.Coi.2005.04.009  0.594
Show low-probability matches.